Lifeward

Lifeward Financing Cash Flow

The Net Financing Cash Flow of Lifeward (LFWD) as of Nov 22, 2026 is 12.20 M USD.

Financing Cash Flow

12.20 MUSD

Last updated:

Net Financing Cash Flow of Lifeward is 2025 12.20 M USD. Net Financing Cash Flow of Lifeward was 2024 0.00 USD. It decreases by % higher compared to the previous year.

The Lifeward Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2018
9.71 M USD
Jan 1, 2019
21.48 M USD
Jan 1, 2020
16.72 M USD
Jan 1, 2021
79.51 M USD
Jan 1, 2022
-2.50 M USD
Jan 1, 2023
-992,000.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
12.20 M USD
The Lifeward Financing Cash Flow history
YEARFinancing Cash FlowYoY
12.20 MUSD—
0.00USD-100.00%
-992,000.00USD-60.32%
-2.50 MUSD-103.14%
79.51 MUSD+375.44%
16.72 MUSD-22.15%
21.48 MUSD+121.21%
9.71 MUSD-27.57%
13.41 MUSD-60.31%
33.78 MUSD+24,559.12%
137,000.00USD-99.73%
50.12 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lifeward Stock analysis

What does Lifeward do? Rewalk Robotics Ltd is a publicly traded company specializing in the development and manufacture of exoskeletons that enable individuals with spinal injuries or paralysis to regain mobility. It was founded in 2001 and is based in Marlborough, Massachusetts. The company's goal is to provide individuals with mobility impairments the opportunity for greater freedom of movement and improved quality of life. Rewalk Robotics has launched various products in the field of rehabilitation and industrial applications, and it continues to research and develop new applications for its technology. The exoskeletons use a combination of motors, sensors, and control systems to allow users to stand, walk, and even climb stairs. In addition to medical applications, Rewalk Robotics also provides exoskeletons for industrial use, enhancing worker safety and productivity. The company is actively involved in research and development to expand the therapeutic possibilities of exoskeletons for neurologic conditions such as stroke and Parkinson's disease. Rewalk Robotics is dedicated to innovation and technology, aiming to improve the lives of millions worldwide by providing greater mobility and autonomy. Lifeward is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifeward stock

Net Financing Cash Flow of Lifeward is 12.20 M USD in 2025.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Lifeward since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Lifeward historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Lifeward

All Key Metrics — Lifeward